Request Deal Involvement

General Catalyst led a $72m Series A round in Maxion Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

ICR Healthcare

pr advisors

ICR Healthcare

FGS Global

pr advisors

FGS Global

or

Principals

MAXION THERAPEUTICS

target

MAXION THERAPEUTICS

GENERAL CATALYST PARTNERS

bidder

GENERAL CATALYST PARTNERS

BRITISH PATIENT CAPITAL

bidder

BRITISH PATIENT CAPITAL

SOLASTA VENTURES

bidder

SOLASTA VENTURES

ELI LILLY AND COMPANY

bidder

ELI LILLY AND COMPANY

LIFEARC VENTURES

bidder

LIFEARC VENTURES

MONOGRAPH CAPITAL

bidder

MONOGRAPH CAPITAL

BGF INVESTMENTS LP

bidder

BGF INVESTMENTS LP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - General Catalyst led a $72m Series A round in Maxion Therapeutics.